Smith J A, Gaynor J S, Bednarski R M, Muir W W
Department of Veterinary Clinical Sciences, Ohio State University, Columbus 43210-1089.
J Am Vet Med Assoc. 1993 Apr 1;202(7):1111-5.
The effects of propofol on anesthetic induction were evaluated in 40 dogs anesthetized with isoflurane. Propofol is a rapidly acting, nonbarbiturate drug that induces anesthesia of ultrashort duration with IV administration. Four preanesthetic regimens were used: anesthesia without preanesthetic drugs; or with preanesthetic administration of acepromazine (0.1 mg/kg of body weight, IM), diazepam (0.2 mg/kg, IV), or acepromazine (0.02 mg/kg) and butorphanol (0.4 mg/kg) IM. Heart rate, systolic arterial blood pressure (SAP), respiration, quality of induction and recovery, and adverse effects were induction and recovery, and adverse effects were recorded. Intravenous propofol administration induced a variable period of apnea in 34 of 40 dogs. Cyanosis (in 2 dogs) and signs of pain on injection (in 3 dogs) were infrequently observed during induction. One dog developed ventricular premature depolarizations after propofol administration. Venous CO2 tension increased and pH decreased immediately after propofol administration, regardless of preanesthetic regimen. The SAP significantly (P < 0.05) decreased after propofol administration in dogs treated with acepromazine (SAP, 178 mm of Hg before vs 128 mm of Hg after propofol) and with acepromazine/butorphanol (SAP, 184 mm of Hg before vs 98 mm of Hg after propofol). When used for induction, propofol induces anesthetic-related adverse effects, some of which can be minimized by preanesthetic medication. Recovery characteristics varied with preanesthetic medication, independent of propofol administration.
在40只接受异氟烷麻醉的犬中评估了丙泊酚对麻醉诱导的影响。丙泊酚是一种起效迅速的非巴比妥类药物,静脉给药可诱导超短时间的麻醉。使用了四种麻醉前给药方案:不使用麻醉前药物;或麻醉前给予乙酰丙嗪(0.1mg/kg体重,肌肉注射)、地西泮(0.2mg/kg,静脉注射),或乙酰丙嗪(0.02mg/kg)和布托啡诺(0.4mg/kg)肌肉注射。记录心率、收缩期动脉血压(SAP)、呼吸、诱导和恢复质量以及不良反应。静脉注射丙泊酚后,40只犬中有34只出现了不同时长的呼吸暂停。诱导期间很少观察到发绀(2只犬)和注射时的疼痛迹象(3只犬)。1只犬在注射丙泊酚后出现室性早搏。无论麻醉前给药方案如何,丙泊酚给药后静脉血二氧化碳张力立即升高,pH值下降。在接受乙酰丙嗪治疗的犬(丙泊酚给药前SAP为178mmHg,给药后为128mmHg)和接受乙酰丙嗪/布托啡诺治疗的犬(丙泊酚给药前SAP为184mmHg,给药后为98mmHg)中,丙泊酚给药后SAP显著降低(P<0.05)。当用于诱导时,丙泊酚会引发与麻醉相关的不良反应,其中一些可通过麻醉前用药降至最低。恢复特征因麻醉前用药而异,与丙泊酚给药无关。